Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients Multi-year study will use Congenica’s platform for...
News
Passage Bio to Participate in Upcoming April Investor Conferences
PHILADELPHIA, March 25, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative...
AGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP Trials
-AGTC’s deep commitment to the patient voice drives solutions to support patient access to information and to improve the experience...
Medicenna Announces Preclinical Data on MDNA11 with Anti-PD-1 Therapy and Unveils Novel Bifunctional Superkines at the Cytokine-Based Cancer Immunotherapies Summit
-- MDNA11 and anti-PD-1 combination leads to complete responses in a murine solid tumor model -- Preclinical data demonstrates the...
MatriSys Bioscience Names Joyce Rico as Chief Medical Officer
LA JOLLA, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin...
G1 Therapeutics’ COSELA™ (trilaciclib) Included in Two Updated National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology
COSELA Added to Both the NCCN Treatment Guidelines for Small Cell Lung Cancer and the NCCN Supportive Care Guidelines for...
Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights
SOUTH SAN FRANCISCO, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Today Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company...
InflaRx Reports Full Year 2020 Financial & Operating Results
Submitted a Special Protocol Assessment to the FDA for Phase III program evaluating vilobelimab in Hidradenitis Suppurativa (HS) in Q1...
Philips to sell its Domestic Appliances business to global investment firm Hillhouse Capital
Philips Airfryer XXL Philips SpeedPro Max March 25, 2021 Transaction values Domestic Appliances at an enterprise value of approximately EUR...
Inozyme Pharma Reports Full Year 2020 Financial Results and Provides Business Highlights
– Received Orphan Drug Designation by the U.S. Food and Drug Administration for INZ-701 for treatment of ABCC6 deficiency –...
Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering
SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal...
Convening of the Ordinary General Meetings of Shareholders of 30 April 2021
CONVENING OF THE ORDINARY GENERAL MEETINGS OF SHAREHOLDERS OF 30 APRIL 2021 The shareholders are invited to attend the ordinary general...
Therma Bright Receives IRB Approval and Submits Application to Health Canada to Begin Clinical Study for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - March 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the...
McKesson Approved as QCDR for 2021 MIPS Program Year
Eight custom measures receive approval, raising the bar on oncology patient care IRVING, Texas--(BUSINESS WIRE)--For the fifth consecutive year, McKesson...
LivaNova to Host Conference Call for First Quarter 2021 Results
LONDON--(BUSINESS WIRE)--$LIVN--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first...
Philips Ranks Among Top 50 Employers for Multicultural Employees
Equal Opportunity magazine readers recognize Philips for its commitment to fostering a diverse and inclusive workforce CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips...
Health Fidelity Celebrates 5 Years of NLP Powered Clinical Suspects, 10 Years of Risk Adjustment
SAN MATEO, Calif.--(BUSINESS WIRE)--#NLP--For Health Fidelity Inc., a company that provides innovative technologies for the value-based care era, 2021 marks...
Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix(R) (varenicline) in Addiction
Subjects treated with cytisinicline were 55% more likely to quit smoking at 6 months and experienced significantly fewer side effects...
World Class Extractions Reports Operating and Financial Results for the Nine-Month Period Ended January 31, 2021
World-Class continues to show substantial revenue growth quarter-over-quarter with revenue of $2,649,140 for the quarter ended January 31, 2021 compared...
Midatech Pharma PLC Announces MTX110 Update & Headline Results for 2020
Non-binding Heads of Terms for Co-development of MTX110; Unaudited Headline Results for the Year Ended 31 December 2020 ABINGDON, UK / ACCESSWIRE...